国泰海通证券股份有限公司 关于 之 发行保荐书 保荐人（主承销商） （中国（上海）自由贸易试验区商城路 618 号） 二〇二五年四月 兄弟科技股份有限公司 2023年度向特定对象发行A股股票 发行保荐书 国泰海通证券股份有限公司 深圳证券交易所： 国泰海通证券股份有限公司（以下简称"国泰海通"、"保荐人"或"本保 荐人"）接受兄弟科技股份有限公司（以下简称"兄弟科技"、"公司"或"发行 人"）的委托，担任兄弟科技本次向特定对象发行 A 股股票的保荐人。国泰海通 及其保荐代表人根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司证券发行注册管理 办法》（以下简称"《注册管理办法》"）、《证券发行上市保荐业务管理办法》（以 下简称"《保荐管理办法》"）等法律法规和中国证券监督管理委员会（以下简称 "中国证监会"）、深圳证券交易所（以下简称"深交所"）的有关规定，诚实守 信，勤勉尽责，严格按照依法制订的业务规则、行业执业规范和道德准则出具 本发行保荐书，并保证本发行保荐书的真实性、准确性和完整性。 本发行保荐书中如无特别说明，相关用语具有与《兄弟科 ...

国泰海通证券股份有限公司 关于 兄弟科技股份有限公司 2023年度向特定对象发行A股股票 之 上市保荐书 保荐人（主承销商） （中国（上海）自由贸易试验区商城路 618 号） 二〇二五年四月 兄弟科技股份有限公司 上市保荐书 国泰海通证券股份有限公司 关于兄弟科技股份有限公司 2023 年度向特定对象发行 A 股股票 之上市保荐书 深圳证券交易所： 国泰海通证券股份有限公司（以下简称"国泰海通"、"保荐人"或"本保 荐人"）接受兄弟科技股份有限公司（以下简称"兄弟科技"、"公司"或"发 行人"）的委托，担任兄弟科技本次向特定对象发行 A 股股票的保荐人。国泰 海通及其保荐代表人根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司证券发行 注册管理办法》（以下简称"《注册管理办法》"）、《证券发行上市保荐业务 管理办法》（以下简称"《保荐管理办法》"）等法律法规和中国证券监督管理 委员会（以下简称"中国证监会"）、深圳证券交易所（以下简称"深交所"） 的有关规定，诚实守信，勤勉尽责，严格按照依法制订的业务规则、行业执业规 范和道德准则出具本上市 ...

Group 1 - The US government has temporarily exempted certain electronic products from tariffs, but this exemption is not permanent and will last only until a new tariff plan for the semiconductor industry is established [2][21] - China's foreign trade in the first quarter of this year reached 10.3 trillion yuan, a year-on-year increase of 1.3%, with exports growing by 6.9% and imports declining by 6% [3] - The State Administration for Market Regulation in China has introduced 37 key measures to support the development of private enterprises, focusing on breaking down barriers and promoting fair competition [4][5] Group 2 - Hong Kong is preparing to attract Chinese concept stocks back to its market, emphasizing its stability and attractiveness amid global financial market volatility [6][7] - The China Securities Regulatory Commission has emphasized the importance of functionality in the fund industry, aiming for a balance between quality and scale [8] - Insurance funds are accelerating their entry into the stock market, with the scale of long-term stock investment trials increasing from 50 billion yuan to 162 billion yuan [9] Group 3 - The US is experiencing a significant drop in import orders, with a 64% decrease in overall import volume, indicating potential disruptions in trade due to tariff policies [10][11] - The total share of stock ETFs in A-shares has surpassed 2 trillion shares, marking a historical high, with substantial inflows of capital observed in April [12] - Global pension funds are pausing investments in US assets due to uncertainties stemming from aggressive tariff policies, indicating a shift in investment strategies [13] Group 4 - The AI industry is facing scrutiny over its energy consumption, with Elon Musk's AI company xAI being investigated for violating environmental regulations related to its power generation [14] - The UK government plans to take over the British Steel Company from a Chinese firm, raising concerns about foreign investments in critical industries [15] - The consumer electronics sector is seeing increased research interest, driven by strong domestic demand policies and a surge in M&A activities in the technology field [17]

Financial Performance - Total revenue for 2024 reached CNY 3,441,405,206.38, representing a year-on-year increase of 21.99%[4] - Operating profit was CNY 52,128,495.19, a significant turnaround from a loss of CNY 154,384,396.97 in the previous year, marking a growth of 133.77%[4] - Net profit attributable to shareholders was CNY 39,816,742.45, compared to a loss of CNY 175,468,814.06 last year, reflecting an increase of 122.69%[4] - The basic earnings per share improved to CNY 0.04 from a loss of CNY 0.17, representing a growth of 123.53%[4] - The weighted average return on net assets was 1.29%, recovering from -5.48% in the previous year[4] Assets and Equity - The company's total assets at the end of the reporting period were CNY 5,871,268,545.38, a slight decrease of 0.26% year-on-year[5] - Shareholders' equity increased by 1.46% to CNY 3,098,704,322.83 compared to the beginning of the period[5] Revenue Drivers - The increase in revenue and profit was attributed to rising prices of certain vitamin products and improved production capacity[5] Reporting and Forecasts - The company confirmed that there were no discrepancies between the reported results and previous earnings forecasts[6] - Detailed financial data will be disclosed in the 2024 annual report[7]

Financial Performance Forecast - The company expects a net profit attributable to shareholders of 18 million to 23 million yuan for Q1 2025, compared to a loss of 25.2047 million yuan in the same period last year[2] - The net profit after deducting non-recurring gains and losses is projected to be between 16 million and 21 million yuan, compared to a loss of 25.7975 million yuan year-on-year[2] - Basic earnings per share are anticipated to be between 0.017 yuan and 0.022 yuan, recovering from a loss of 0.024 yuan per share in the previous year[2] - The company achieved a turnaround from loss to profit primarily due to the increase in sales prices of certain vitamin products[5] Audit and Reporting - The performance forecast has not been audited by registered accountants[4] - The financial data provided is preliminary and will be detailed in the company's Q1 2025 report[6] - The company has communicated with the accounting firm regarding the performance forecast, and there are no discrepancies[3] Investor Awareness - The company emphasizes the importance of investors being aware of investment risks[7] Performance Period - The performance forecast period is from January 1, 2025, to March 31, 2025[2] Announcement Details - The announcement was made by the company's board of directors on April 15, 2025[8]

兄弟科技（002562）公告，2024年度实现营业总收入34.41亿元，同比增长21.99%；营业利润5212.85万 元，同比增长133.77%；利润总额5033.43万元，同比增长131.69%；归属于上市公司股东的净利润 3981.67万元，同比增长122.69%；扣除非经常性损益后的归属于上市公司股东的净利润3078.6万元，同 比增长113.19%；基本每股收益0.04元，同比增长123.53%；加权平均净资产收益率1.29%，同比增长 6.77%。 ...

Core Viewpoint - The company, Brother Technology (002562), is expected to report a net profit attributable to shareholders of 18 million to 23 million yuan for the first quarter of 2025, marking a turnaround from a loss of 25.2047 million yuan in the same period last year [1] Financial Performance - The net profit after deducting non-recurring gains and losses is projected to be between 16 million and 21 million yuan, compared to a loss of 25.7975 million yuan in the previous year [1] - The basic earnings per share are estimated to be between 0.017 yuan and 0.022 yuan, a significant improvement from a loss of 0.024 yuan per share in the same quarter last year [1] Sales Performance - The turnaround to profitability is primarily attributed to the increase in sales prices of certain vitamin products compared to the previous year [1]

中国经济网北京4月12日讯兄弟科技（002562）(002562.SZ)昨日晚间披露关于申请向特定对象发行股票获 得深圳证券交易所上市审核中心审核通过的公告。兄弟科技于2025年4月11日收到深圳证券交易所(以下简 称"深交所")上市审核中心出具的《关于兄弟科技股份有限公司申请向特定对象发行股票的审核中心意见告 知函》，深交所发行上市审核机构对公司向特定对象发行股票的申请文件进行了审核，认为公司符合发行 条件、上市条件和信息披露要求，后续深交所将按规定报中国证券监督管理委员会(以下简称"中国证监 会")履行相关注册程序。 兄弟科技本次发行的保荐机构为国泰海通证券股份有限公司，保荐代表人为朱浩、周琦。 兄弟科技3月26日发布的2023年度向特定对象发行A股股票预案(五次修订稿)显示，经调整后，本次发行募 集资金总额不超过43,675.00万元(含本数)，募集资金扣除相关发行费用后将用于投资年产1,150吨碘造影剂 原料药建设项目。 本次发行的对象为不超过35名特定投资者，包括符合中国证监会规定的证券投资基金管理公司、证券公 司、信托公司、财务公司、保险机构投资者、合格境外机构投资者以及其他符合相关法律、法规规定 ...

免疫诊断方向，已基本完成覆盖高中低通量的仪器布局，包括三款全自动化学发光免疫分析仪 （Caris200、Wan200+、Wan100）以及配套115项试剂，满足临床检验各种应用场景的核心需求，公司 国产自研的一款高速化学发光免疫分析仪Wan600开发已经进入行政审批阶段，将进一步提升检测效率 和准确性。生化诊断方向，公司推出一款高通量全自动生化分析仪WanBC2800。 西部矿业2024年净利润同比增长5% -- 重点要闻– 万泰生物2024年净利润1.06亿元 万泰生物(603392.SH)发布2024年年报，致力于为我国临床医疗体系提供优质、全面的体外诊断解决方 案。2024年营业收入为22.45亿元，相较上年同比减少-59.25%；归属于上市公司股东的净利润1.06亿 元，同比减少91.49%；归属于上市公司股东的扣除非经常性损益的净利润-1.86亿元，同比减少 117.29%。 | | | | 甲 W: 儿 | 1114: Acch | | --- | --- | --- | --- | --- | | 主要会计数据 | 2024年 | 2023年 | 本期比上年 同期增减 | 2022年 | | | ...

兄弟科技股份有限公司 关于申请向特定对象发行股票获得深圳证券交易所 上市审核中心审核通过的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 股票代码：002562 股票简称：兄弟科技 公告编号：2025-016 公司将根据该事项的进展情况，按照有关规定和要求及时履行信息披露义务，敬请广大 投资者注意投资风险。 特此公告。 兄弟科技股份有限公司 董事会 2025年4月12日 1 兄弟科技股份有限公司（以下简称"公司"）于2025年4月11日收到深圳证券交易所（以 下简称"深交所"）上市审核中心出具的《关于兄弟科技股份有限公司申请向特定对象发行股 票的审核中心意见告知函》，深交所发行上市审核机构对公司向特定对象发行股票的申请文件 进行了审核，认为公司符合发行条件、上市条件和信息披露要求，后续深交所将按规定报中 国证券监督管理委员会（以下简称"中国证监会"）履行相关注册程序。 公司本次向特定对象发行股票事项尚需获得中国证监会作出同意注册的决定后方可实施， 最终能否获得中国证监会同意注册的决定及其时间尚存在不确定性。 ...